Point72 Asset Management L.P. purchased a new stake in Endava plc (NYSE:DAVA - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 57,063 shares of the company's stock, valued at approximately $1,763,000. Point72 Asset Management L.P. owned 0.10% of Endava at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. Assetmark Inc. boosted its position in shares of Endava by 93.1% in the fourth quarter. Assetmark Inc. now owns 985 shares of the company's stock valued at $30,000 after acquiring an additional 475 shares during the period. Blue Trust Inc. increased its stake in shares of Endava by 28.5% in the fourth quarter. Blue Trust Inc. now owns 1,494 shares of the company's stock valued at $46,000 after buying an additional 331 shares during the period. Quadrant Capital Group LLC boosted its holdings in Endava by 114.2% in the fourth quarter. Quadrant Capital Group LLC now owns 1,474 shares of the company's stock valued at $46,000 after acquiring an additional 786 shares during the last quarter. State of Tennessee Department of Treasury bought a new position in shares of Endava during the 4th quarter worth approximately $100,000. Finally, PNC Financial Services Group Inc. boosted its holdings in shares of Endava by 60.4% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,086 shares of the company's stock worth $126,000 after buying an additional 1,538 shares in the last quarter. 62.23% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several brokerages have recently issued reports on DAVA. Susquehanna decreased their target price on Endava from $50.00 to $42.00 and set a "positive" rating for the company in a research report on Tuesday, May 20th. Morgan Stanley raised their target price on Endava from $33.00 to $35.00 and gave the company an "equal weight" rating in a research report on Friday, January 31st. Cowen lowered Endava from a "buy" rating to a "hold" rating in a report on Wednesday, May 14th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $18.00 price objective on shares of Endava in a report on Monday, May 19th. Finally, Needham & Company LLC decreased their price objective on Endava from $22.00 to $18.00 and set a "buy" rating for the company in a report on Thursday, May 15th. Six research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, Endava has a consensus rating of "Hold" and a consensus target price of $26.75.
Read Our Latest Stock Analysis on Endava
Endava Price Performance
NYSE:DAVA traded up $0.13 during mid-day trading on Tuesday, reaching $14.28. The stock had a trading volume of 140,390 shares, compared to its average volume of 521,013. The firm has a 50 day moving average price of $18.17 and a two-hundred day moving average price of $25.31. The stock has a market capitalization of $842.96 million, a P/E ratio of 129.68, a P/E/G ratio of 2.26 and a beta of 1.25. Endava plc has a one year low of $14.00 and a one year high of $34.94. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 1.90.
About Endava
(
Free Report)
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Featured Stories

Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.